ANTIHYPERTENSIVE EFFECTS OF NIGULDIPINE-HCL (B 844-39), A NEW CALCIUM-ANTAGONIST IN DOGS

被引：13

作者：

FISCHER, G

KRUMPL, G

MAYER, N

SCHNEIDER, W

RABERGER, G

机构：

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1987年 / 10卷 / 03期

关键词：

D O I：

10.1097/00005344-198709000-00003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：268 / 273

页数：6

共 23 条

[11]

KNORR A, 1981, ARZNEIMITTELFORSCH, V12, P2062

[12]

LARAGH JH, 1984, J CARDIOVASC PHARM, V6, P1067

[13]

LEONETTI G, 1982, J CARDIOVASC PHARM, V4, pS319

[14]

MACGREGOR GA, 1982, J CARDIOVASC PHARM, V4, pS358

[15] CALCIUM-ANTAGONISTS AND ISLET FUNCTION .12. COMPARISON BETWEEN NIFEDIPINE AND CHEMICALLY RELATED DRUGS [J].

MALAISSE, WJ ;

SENER, A .

BIOCHEMICAL PHARMACOLOGY, 1981, 30 (10) :1039-1041

[16]

MUIESAN G, 1982, J CARDIOVASC PHARM, V4, pS325

[17]

Page IH, 1939, J AMER MED ASSOC, V113, P2046

[18]

Pedersen O L, 1981, Acta Pharmacol Toxicol (Copenh), V49 Suppl 2, P1

[19] A MODEL OF TRANSIENT MYOCARDIAL DYSFUNCTION IN CONSCIOUS DOGS - REGIONAL SHORTENING IN THE PRESENCE OF IMPAIRED CORONARY FLOW RESERVE AND TREADMILL EXERCISE [J].

RABERGER, G ;

KRUMPL, G ;

MAYER, N .

JOURNAL OF PHARMACOLOGICAL METHODS, 1986, 16 (01) :23-37

[20] MECHANISMS UNDERLYING THE CARDIOVASCULAR ACTION OF A NEW DIHYDROPYRIDINE VASODILATOR, YC-93 [J].

SATOH, K ;

YANAGISAWA, T ;

TAIRA, N .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1980, 7 (03) :249-262

← 1 2 3 →